Alfonso Del Arco Jiménez

Dr. Alfonso Del Arco Jiménez

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2013 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
LLLuis Eduardo López-Cortés
Luis Eduardo López-Cortés
MLMaría Dolores del Toro López
María Dolores del Toro López
JGJuan Gálvez-Acebal
Juan Gálvez-Acebal
EBElena Bereciartua-Bastarrica
Elena Bereciartua-Bastarrica
MFMaría Carmen Fariñas
María Carmen Fariñas
VMVictoria Manzano-Gamero
Victoria Manzano-Gamero
Background. Staphylococcus aureus bacteremia (SAB) is associated with significant morbidity and mortality. Several aspects of clinical management have been shown to have significant impact on prognosis. The objective of the study was to identify evidence-based quality-of-care indicators (QCIs) for the management of SAB, and to evaluate the impact of a QCI-based bundle on the management and prognosis of SAB. Methods. A systematic review of the literature to identify QCIs in the management of SAB was performed. Then, the impact of a bundle including selected QCIs was evaluated in a quasi-experimental study in 12 tertiary Spanish hospitals. The main and secondary outcome variables were adherence to QCIs and mortality. Specific structured individualized written recommendations on 6 selected evidence-based QCIs for the management of SAB were provided. Results. A total of 287 and 221 patients were included in the preintervention and intervention periods, respectively. After controlling for potential confounders, the intervention was independently associated with improved adherence to follow-up blood cultures (odds ratio [OR], 2.83; 95% confidence interval [CI], 1.78–4.49), early source control (OR, 4.56; 95% CI, 2.12–9.79), early intravenous cloxacillin for methicillin-susceptible isolates (OR, 1.79; 95% CI, 1.15–2.78), and appropriate duration of therapy (OR, 2.13; 95% CI, 1.24–3.64). The intervention was independently associated with a decrease in 14-day and 30-day mortality (OR, 0.47; 95% CI, .26–.85 and OR, 0.56; 95% CI, .34–.93, respectively). Conclusions. A bundle orientated to improving adherence to evidence-based QCIs improved the management of patients with SAB and was associated with reduced mortality.

1 January 2012 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
PRPilar Retamar
Pilar Retamar
MPMaría M. Portillo
María M. Portillo
MLMaría Dolores López-Prieto
María Dolores López-Prieto
FRFernando Rodríguez-López
Fernando Rodríguez-López
MCMarina de Cueto
Marina de Cueto
TGthe SAEI/SAMPAC Bacteremia Group
the SAEI/SAMPAC Bacteremia Group
The impact of the adequacy of empirical therapy on outcome for patients with bloodstream infections (BSI) is key for determining whether adequate empirical coverage should be prioritized over other, more conservative approaches. Recent systematic reviews outlined the need for new studies in the field, using improved methodologies. We assessed the impact of inadequate empirical treatment on the mortality of patients with BSI in the present-day context, incorporating recent methodological recommendations. A prospective multicenter cohort including all BSI episodes in adult patients was performed in 15 hospitals in Andalucía, Spain, over a 2-month period in 2006 to 2007. The main outcome variables were 14- and 30-day mortality. Adjusted analyses were performed by multivariate analysis and propensity score-based matching. Eight hundred one episodes were included. Inadequate empirical therapy was administered in 199 (24.8%) episodes; mortality at days 14 and 30 was 18.55% and 22.6%, respectively. After controlling for age, Charlson index, Pitt score, neutropenia, source, etiology, and presentation with severe sepsis or shock, inadequate empirical treatment was associated with increased mortality at days 14 and 30 (odds ratios [ORs], 2.12 and 1.56; 95% confidence intervals [95% CI], 1.34 to 3.34 and 1.01 to 2.40, respectively). The adjusted ORs after a propensity score-based matched analysis were 3.03 and 1.70 (95% CI, 1.60 to 5.74 and 0.98 to 2.98, respectively). In conclusion, inadequate empirical therapy is independently associated with increased mortality in patients with BSI. Programs to improve the quality of empirical therapy in patients with suspicion of BSI and optimization of definitive therapy should be implemented.

1 May 2019 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
LMLaura Morata
Laura Morata
JCJ. Cobo
J. Cobo
MFM. Fernández-Sampedro
M. Fernández-Sampedro
PGPablo Guisado-Vasco
Pablo Guisado-Vasco
ERE. Ruano
E. Ruano
ASA. Soriano
A. Soriano
Dalbavancin is a lipoglycopeptide with potent activity against Gram-positive microorganisms, a long half-life, a favorable safety profile, and a high concentration in bone, which makes it an interesting alternative for treatment of osteoarticular infections. We performed a multicentric retrospective study of all patients with an osteoarticular infection (septic arthritis, spondylodiscitis, osteomyelitis, or orthopedic implant-related infection) treated with at least one dose of dalbavancin between 2016 and 2017 in 30 institutions in Spain.

1 June 2005 in Quality of Life Research
Verified
Journal Article
Closed access
PDF file
IRISABEL RUIZ-PÉREZ
ISABEL RUIZ-PÉREZ
JBJesus Rodríguez Baño
Jesus Rodríguez Baño
MRM. A. Lopez Ruz
M. A. Lopez Ruz
AJAlfonso Del Arco Jiménez
Alfonso Del Arco Jiménez
MPM. Causse Prados
M. Causse Prados
MMM. Marcos
M. Marcos

1 August 1991 in Seminars in Arthritis and Rheumatism
Verified
Journal Article
Closed access
SFS.Muñoz Fernandez
S.Muñoz Fernandez
ACA. Cardenal
A. Cardenal
ABA. Balsa
A. Balsa
JQJ. Quiralte
J. Quiralte
AJAlfonso Del Arco Jiménez
Alfonso Del Arco Jiménez
JGJ. Gijón
J. Gijón

10 September 2015 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
FFFelipe Fernández-Cuenca
Felipe Fernández-Cuenca
Maria TomasMaria Tomas
Maria Tomas
FCFrancisco-Javier Caballero-Moyano
Francisco-Javier Caballero-Moyano
GBGermán Bou
Germán Bou
LMLuis Martínez Martínez
Luis Martínez Martínez
CQCristóbal del Rosario Q
Cristóbal del Rosario Q
The objective of this study was to analyse whether there is an association between reduced susceptibility to biocides in Acinetobacter baumannii and (i) antimicrobial resistance (co-resistance), (ii) prevalent (epidemic) clones, (iii) changes in the fitness or (iv) expression of genes related to efflux pumps and porins. Susceptibility to biocides and antimicrobials was determined in 49 clonally unrelated isolates of A. baumannii. Biological cost, in terms of mean generation time, was determined by spectrophotometry. Quantitative real-time RT–PCR was used to determine the relative expression of genes encoding several efflux pumps and porins. Reduced susceptibility to chlorhexidine digluconate, benzalkonium chloride and Irgasan® was associated with resistance to aminoglycosides, tetracycline and ciprofloxacin (P < 0.05). The MICs of carbapenems, aminoglycosides, doxycycline and ciprofloxacin for isolate Ab70 (epidemic clone) exposed to these biocides increased by ≥2 dilutions. Reduced susceptibility to Orsan® was more frequent among prevalent clones than non-prevalent clones (P < 0.05). Mean generation times for Ab70 before and after exposure to benzalkonium chloride were 57.8 and 78.1 min, respectively (P = 0.02). Relative expression of abeS and adeB was increased in Ab46 and Ab70 after exposure to chlorhexidine digluconate, but was decreased for ompA and carO after exposure to Irgasan®. Reduced susceptibility to biocides is associated with co-resistance to carbapenems, aminoglycosides, tetracycline and ciprofloxacin. Reduced susceptibility to Orsan® may be a marker of prevalent clones. Acquisition of reduced susceptibility to benzalkonium chloride has a biological cost. Exposure to biocides affects the relative expression of genes related to some efflux pump genes (increased expression) or porins (reduced expression).